201 related articles for article (PubMed ID: 31679100)
1. In vitro cellular uptake and neuroprotective efficacy of poly-arginine-18 (R18) and poly-ornithine-18 (O18) peptides: critical role of arginine guanidinium head groups for neuroprotection.
MacDougall G; Anderton RS; Ouliel E; Gao J; Redmond SL; Knuckey NW; Meloni BP
Mol Cell Biochem; 2020 Jan; 464(1-2):27-38. PubMed ID: 31679100
[TBL] [Abstract][Full Text] [Related]
2. Poly-arginine-18 (R18) Confers Neuroprotection through Glutamate Receptor Modulation, Intracellular Calcium Reduction, and Preservation of Mitochondrial Function.
MacDougall G; Anderton RS; Trimble A; Mastaglia FL; Knuckey NW; Meloni BP
Molecules; 2020 Jun; 25(13):. PubMed ID: 32610439
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine-Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion in Rats.
Meloni BP; Milani D; Cross JL; Clark VW; Edwards AB; Anderton RS; Blacker DJ; Knuckey NW
Neuromolecular Med; 2017 Sep; 19(2-3):271-285. PubMed ID: 28523591
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of neuroprotective efficacy of modified poly-arginine-9 (R9) peptides using a neuronal glutamic acid excitotoxicity model.
Edwards AB; Anderton RS; Knuckey NW; Meloni BP
Mol Cell Biochem; 2017 Feb; 426(1-2):75-85. PubMed ID: 27844251
[TBL] [Abstract][Full Text] [Related]
5. Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat.
Edwards AB; Cross JL; Anderton RS; Knuckey NW; Meloni BP
Mol Brain; 2018 Feb; 11(1):8. PubMed ID: 29426351
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of cortical neuronal cultures treated with poly-arginine peptide-18 (R18) and exposed to glutamic acid excitotoxicity.
MacDougall G; Anderton RS; Mastaglia FL; Knuckey NW; Meloni BP
Mol Brain; 2019 Jul; 12(1):66. PubMed ID: 31315638
[TBL] [Abstract][Full Text] [Related]
7. Assessment of R18, COG1410, and APP96-110 in Excitotoxicity and Traumatic Brain Injury.
Chiu LS; Anderton RS; Cross JL; Clark VW; Edwards AB; Knuckey NW; Meloni BP
Transl Neurosci; 2017; 8():147-157. PubMed ID: 29177102
[TBL] [Abstract][Full Text] [Related]
8. Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies.
Milani D; Bakeberg MC; Cross JL; Clark VW; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
PLoS One; 2018; 13(3):e0193884. PubMed ID: 29513757
[TBL] [Abstract][Full Text] [Related]
9. Poly-arginine and arginine-rich peptides are neuroprotective in stroke models.
Meloni BP; Brookes LM; Clark VW; Cross JL; Edwards AB; Anderton RS; Hopkins RM; Hoffmann K; Knuckey NW
J Cereb Blood Flow Metab; 2015 Jun; 35(6):993-1004. PubMed ID: 25669902
[TBL] [Abstract][Full Text] [Related]
10. Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model.
Milani D; Clark VW; Cross JL; Anderton RS; Knuckey NW; Meloni BP
BMC Neurosci; 2016 May; 17(1):19. PubMed ID: 27142074
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties.
Meloni BP; Milani D; Edwards AB; Anderton RS; O'Hare Doig RL; Fitzgerald M; Palmer TN; Knuckey NW
Pharmacol Ther; 2015 Sep; 153():36-54. PubMed ID: 26048328
[TBL] [Abstract][Full Text] [Related]
12. The Neuroprotective Peptide Poly-Arginine-12 (R12) Reduces Cell Surface Levels of NMDA NR2B Receptor Subunit in Cortical Neurons; Investigation into the Involvement of Endocytic Mechanisms.
MacDougall G; Anderton RS; Edwards AB; Knuckey NW; Meloni BP
J Mol Neurosci; 2017 Feb; 61(2):235-246. PubMed ID: 27866326
[TBL] [Abstract][Full Text] [Related]
13. Comparative Assessment of the Proteolytic Stability and Impact of Poly-Arginine Peptides R18 and R18D on Infarct Growth and Penumbral Tissue Preservation Following Middle Cerebral Artery Occlusion in the Sprague Dawley Rat.
Milani D; Clark VW; Feindel KW; Blacker DJ; Bynevelt M; Edwards AB; Anderton RS; Knuckey NW; Meloni BP
Neurochem Res; 2021 May; 46(5):1166-1176. PubMed ID: 33523394
[TBL] [Abstract][Full Text] [Related]
14. Poly-arginine-18 peptides do not exacerbate bleeding, or improve functional outcomes following collagenase-induced intracerebral hemorrhage in the rat.
Liddle L; Reinders R; South S; Blacker D; Knuckey N; Colbourne F; Meloni B
PLoS One; 2019; 14(11):e0224870. PubMed ID: 31697775
[TBL] [Abstract][Full Text] [Related]
15. Perinatal Hypoxic-Ischemic Encephalopathy and Neuroprotective Peptide Therapies: A Case for Cationic Arginine-Rich Peptides (CARPs).
Edwards AB; Anderton RS; Knuckey NW; Meloni BP
Brain Sci; 2018 Aug; 8(8):. PubMed ID: 30087289
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective efficacy of poly-arginine R18 and NA-1 (TAT-NR2B9c) peptides following transient middle cerebral artery occlusion in the rat.
Milani D; Cross JL; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
Neurosci Res; 2017 Jan; 114():9-15. PubMed ID: 27639457
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the safety of the cationic arginine-rich peptides (CARPs) poly-arginine-18 (R18 and R18D) in
Edwards AB; Mastaglia FL; Knuckey NW; Yip KH; Meloni B
Biochem Biophys Rep; 2022 Sep; 31():101305. PubMed ID: 35812346
[TBL] [Abstract][Full Text] [Related]
18. The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures.
Meloni BP; Craig AJ; Milech N; Hopkins RM; Watt PM; Knuckey NW
Cell Mol Neurobiol; 2014 Mar; 34(2):173-81. PubMed ID: 24213248
[TBL] [Abstract][Full Text] [Related]
19. Poly-Arginine Peptides R18 and R18D Improve Functional Outcomes After Endothelin-1-Induced Stroke in the Sprague Dawley Rat.
Meloni BP; South SM; Gill DA; Marriott AL; Déziel RA; Jacques A; Blacker DJ; Knuckey NW
J Neuropathol Exp Neurol; 2019 May; 78(5):426-435. PubMed ID: 30888409
[TBL] [Abstract][Full Text] [Related]
20. Cationic Arginine-Rich Peptides (CARPs): A Novel Class of Neuroprotective Agents With a Multimodal Mechanism of Action.
Meloni BP; Mastaglia FL; Knuckey NW
Front Neurol; 2020; 11():108. PubMed ID: 32158425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
